IGC
IGC Pharma·AMEX
--
--(--)
--
--(--)
IGC fundamentals
IGC Pharma (IGC) Revenue Breakdown: Q2 2026 Business & Regional Performance
IGC Pharma (IGC) reported total revenue of 191.00K USD in Q2 2026, with its core business segment Life Sciences Segment contributing 100.00%. Regionally, United States remained the largest market, accounting for 100.00% of total revenue. Explore IGC Pharma's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
IGC Pharma (IGC) reported total revenue of 191.00K USD in Q2 2026, with its core business segment Life Sciences Segment contributing 100.00%. Regionally, United States remained the largest market, accounting for 100.00% of total revenue. Explore IGC Pharma's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from IGC Pharma’s earnings call?Did IGC Pharma beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for IGC Pharma year over year?What is the market's earnings forecast for IGC Pharma next quarter?What guidance did IGC Pharma's management provide for the next earnings period?What is IGC Pharma's gross profit margin?What does IGC Pharma do and what are its main business segments?What factors drove the changes in IGC Pharma's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
